CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
66.23
-0.87 (-1.30%)
At close: May 6, 2025, 4:00 PM
66.00
-0.23 (-0.35%)
After-hours: May 6, 2025, 4:15 PM EDT
CVS Health Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for CVS Health stock have an average target of 75.33, with a low estimate of 62 and a high estimate of 84. The average target predicts an increase of 13.74% from the current stock price of 66.23.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CVS Health stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 5 | 5 | 5 | 4 |
| Buy | 7 | 7 | 8 | 8 | 8 | 8 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 16 | 16 | 16 | 16 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $76 → $84 | Buy | Maintains | $76 → $84 | +26.83% | May 6, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $74 → $81 | Buy | Maintains | $74 → $81 | +22.30% | May 5, 2025 |
| UBS | UBS | Hold Maintains $67 → $71 | Hold | Maintains | $67 → $71 | +7.20% | May 2, 2025 |
| Barclays | Barclays | Buy Maintains $73 → $82 | Buy | Maintains | $73 → $82 | +23.81% | May 2, 2025 |
| Baird | Baird | Hold Maintains $51 → $71 | Hold | Maintains | $51 → $71 | +7.20% | Apr 15, 2025 |
Financial Forecast
Revenue This Year
393.35B
from 370.66B
Increased by 6.12%
Revenue Next Year
412.45B
from 393.35B
Increased by 4.86%
EPS This Year
5.96
from 3.66
Increased by 62.92%
EPS Next Year
6.92
from 5.96
Increased by 15.98%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 419.2B | 446.1B | 482.4B | ||
| Avg | 393.3B | 412.4B | 434.9B | ||
| Low | 374.6B | 383.0B | 399.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.1% | 13.4% | 17.0% | ||
| Avg | 6.1% | 4.9% | 5.5% | ||
| Low | 1.1% | -2.6% | -3.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.83 | 8.06 | 9.45 | ||
| Avg | 5.96 | 6.92 | 7.94 | ||
| Low | 5.52 | 6.07 | 6.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 86.5% | 35.2% | 36.6% | ||
| Avg | 62.9% | 16.0% | 14.8% | ||
| Low | 50.7% | 1.8% | -10.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.